Leuko secures $1.8 mln seed
Boston and Madrid-based Leuko, a developer of a non-invasive white blood cell monitoring device, has raised $1.8 million in seed financing. The investors included Good Growth Capital, Pegasus Tech Ventures and Nina Capital.
17 July 2019•1 min read
